Thiol/disulphide homeostasis in patients with rheumatoid arthritis: a potential link with disease activity and preclinical atherosclerosis

Beyazal S. M., ARPA M., DEVRİMSEL G., YILDIRIM M., EREL Ö., Erdogan T.

Acta Reumatologica Portuguesa, vol.46, no.1, pp.23-31, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 46 Issue: 1
  • Publication Date: 2021
  • Journal Name: Acta Reumatologica Portuguesa
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE, Directory of Open Access Journals
  • Page Numbers: pp.23-31
  • Keywords: Rheumatoid arthritis, Thiol/disulphide homeostasis, Disease activity, Preclinical atherosclerosis
  • Ankara Yıldırım Beyazıt University Affiliated: Yes


© 2021, Acta Reumatologica Portuguesa. All Rights Reserved.Introduction/objectives: Thiols are crucial anti-oxidant agents that contain a sulfhydryl group; they play an important role in defence against reactive oxygen species. We aimed to determine the thiol/disulphide homeostasis in rheumatoid arthritis (RA) patients in conjunction with its association with disease activity, preclinical atherosclerosis, and other disease-related indices. Methods: We enrolled 64 RA patients without known cardiovascular (CV) disease or risk factors and 46 healthy controls. Disease activity was evaluated using the Disease Activity Score 28-erythrocyte sedimentation rate (DAS28-ESR). Thiol/disulphide homeostasis was evaluated using a novel automated method, and serum native thiol (NT), total thiol (TT), and disulphide( SS) levels were recorded. The carotid intima media thickness (CIMT) was measured using carotid ultrasound to evaluate preclinical atherosclerosis. Results: The NT and TT levels were significantly lower in RA patients than in controls (231.7 ± 52.3 vs. 293.6 ± 74.8 μmol/L, p < 0.001; 271.6 ± 52.1 vs. 331.3 ± 68.2 μmol/L, p < 0.001, respectively). There was no difference in SS levels between both groups. The CIMT was significantly higher in RA patients than in controls (0.80 vs. 0.56 mm, p < 0.001). NT levels showed a significant negative correlation withCIMT in patients with RA (r = -0.253, p = 0.040). In RA patients, NT and TT levels were significantly correlated with ESR (r = -0.394, r = -0.399), high-sensitivity C-reactive protein (r = -0.413, r = -0.342), DAS28-ESR (r = -0.279, r = -0.312), fibrinogen level (r = -0.302, r = -0.346), and anti-cyclic citrullinated peptide titres (r = -0.305, r = 0.322) (, respectively). The association of thiol levels with CIMT did not arrive at a statistically significant level in multivariable linear regression analysis. Conclusions: RA patients without known CV disease or risk factors exhibited increased CIMT values and decreased thiol levels; moreover, thiol levels were found to be correlated with disease activity. Further studies are needed to detect the value of thiol/disulphide homeostasis for CV risk stratification and risk prediction in RA patients.